ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

EVOK Evoke Pharma Inc

0.475
0.044 (10.21%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 11,455
Bid Price 0.442
Ask Price 0.54
News -
Day High 0.50

Low
0.40

52 Week Range

High
1.96

Day Low 0.424
Share Name Share Symbol Market Stock Type
Evoke Pharma Inc EVOK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.044 10.21% 0.475 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.424 0.424 0.50 0.475 0.431
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
110 11,455 US$ 0.461712 US$ 5,289 - 0.40 - 1.96
Last Trade Type Quantity Price Currency
15:45:39 95 US$ 0.4898 USD

Evoke Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.24M 8.48M - 5.18M -7.79M -0.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evoke Pharma News

Date Time Source News Article
5/30/202417:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/24/202416:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/16/202415:02GlobeNewswire Inc.Evoke Pharma to Present Additional GIMOTI Healthcare..
5/14/202415:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:15GlobeNewswire Inc.Evoke Pharma Reports First Quarter 2024 Financial Results
5/14/202415:15Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
5/14/202415:00Edgar (US Regulatory)Form 8-K - Current report
4/17/202407:30GlobeNewswire Inc.Evoke Pharma to Host Virtual Key Opinion Leader (KOL)..
3/21/202415:15GlobeNewswire Inc.Evoke Pharma Announces Senior Leadership Transition with..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EVOK Message Board. Create One! See More Posts on EVOK Message Board See More Message Board Posts

Historical EVOK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.450.500.400.43856331,0720.0255.56%
1 Month0.47430.550.400.459020236,0750.00070.15%
3 Months0.7040.760.400.548451335,355-0.229-32.53%
6 Months1.231.450.400.699762543,089-0.755-61.38%
1 Year1.671.960.400.953499531,680-1.20-71.56%
3 Years1.265.960.22611.12570,529-0.785-62.30%
5 Years0.606.06280.22611.70555,236-0.125-20.83%

Evoke Pharma Description

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.